2002Schmid Review

Citation

Schmid MB (2002) Structural proteomics: the potential of highthroughput structure determination. Trends Microbiol 10:S27– S31

Cited by

Abstract

The pharmaceutical industry has embraced genomics as a means to identify new biological targets for target-based drug discovery approaches. Now, genomics is driving a substantial effort in protein structure determination and structure prediction. These structures will provide the opportunity to undertake structure-guided drug discovery programs in the search for new classes of broad-spectrum antibiotics. In addition, these structures could provide structure-based criteria to prioritize certain targets for focused drug discovery programs.

Keywords

Review, single particles

Links

Article http://linkinghub.elsevier.com/retrieve/pii/S0966842X02024435